2-126690264-C-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The ENST00000356887.12(GYPC):​c.-5C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000688 in 1,612,290 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.0037 ( 6 hom., cov: 32)
Exomes 𝑓: 0.00038 ( 1 hom. )

Consequence

GYPC
ENST00000356887.12 5_prime_UTR_premature_start_codon_gain

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.836

Publications

3 publications found
Variant links:
Genes affected
GYPC (HGNC:4704): (glycophorin C (Gerbich blood group)) Glycophorin C (GYPC) is an integral membrane glycoprotein. It is a minor species carried by human erythrocytes, but plays an important role in regulating the mechanical stability of red cells. A number of glycophorin C mutations have been described. The Gerbich and Yus phenotypes are due to deletion of exon 3 and 2, respectively. The Webb and Duch antigens, also known as glycophorin D, result from single point mutations of the glycophorin C gene. The glycophorin C protein has very little homology with glycophorins A and B. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]
GYPC Gene-Disease associations (from GenCC):
  • hereditary elliptocytosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0046405196).
BP6
Variant 2-126690264-C-T is Benign according to our data. Variant chr2-126690264-C-T is described in ClinVar as [Benign]. Clinvar id is 721097.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 558 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GYPCNM_002101.5 linkc.59C>T p.Pro20Leu missense_variant Exon 2 of 4 ENST00000259254.9 NP_002092.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GYPCENST00000356887.12 linkc.-5C>T 5_prime_UTR_premature_start_codon_gain_variant Exon 3 of 5 1 ENSP00000349354.7 P04921-2
GYPCENST00000259254.9 linkc.59C>T p.Pro20Leu missense_variant Exon 2 of 4 1 NM_002101.5 ENSP00000259254.4 P04921-1
GYPCENST00000356887.12 linkc.-5C>T 5_prime_UTR_variant Exon 3 of 5 1 ENSP00000349354.7 P04921-2
GYPCENST00000409836.3 linkc.50-3600C>T intron_variant Intron 1 of 2 1 ENSP00000386904.3 P04921-3

Frequencies

GnomAD3 genomes
AF:
0.00365
AC:
555
AN:
152216
Hom.:
6
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0127
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000385
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00382
GnomAD2 exomes
AF:
0.000971
AC:
244
AN:
251414
AF XY:
0.000707
show subpopulations
Gnomad AFR exome
AF:
0.0123
Gnomad AMR exome
AF:
0.000954
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000704
Gnomad OTH exome
AF:
0.000163
GnomAD4 exome
AF:
0.000377
AC:
551
AN:
1459956
Hom.:
1
Cov.:
30
AF XY:
0.000326
AC XY:
237
AN XY:
726412
show subpopulations
African (AFR)
AF:
0.0125
AC:
419
AN:
33424
American (AMR)
AF:
0.000939
AC:
42
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26124
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39698
South Asian (SAS)
AF:
0.0000348
AC:
3
AN:
86216
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53412
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5752
European-Non Finnish (NFE)
AF:
0.0000324
AC:
36
AN:
1110288
Other (OTH)
AF:
0.000729
AC:
44
AN:
60320
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.457
Heterozygous variant carriers
0
30
61
91
122
152
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00366
AC:
558
AN:
152334
Hom.:
6
Cov.:
32
AF XY:
0.00326
AC XY:
243
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.0127
AC:
529
AN:
41586
American (AMR)
AF:
0.00124
AC:
19
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.000386
AC:
2
AN:
5180
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68030
Other (OTH)
AF:
0.00378
AC:
8
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
30
59
89
118
148
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00114
Hom.:
4
Bravo
AF:
0.00427
ESP6500AA
AF:
0.0141
AC:
62
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00111
AC:
135
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000178

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Mar 30, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

GYPC-related disorder Benign:1
Aug 09, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.11
BayesDel_addAF
Benign
-0.72
T
BayesDel_noAF
Benign
-0.79
CADD
Benign
19
DANN
Benign
0.50
DEOGEN2
Benign
0.016
T
Eigen
Benign
-1.0
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.028
N
LIST_S2
Benign
0.40
T
MetaRNN
Benign
0.0046
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.2
L
PhyloP100
0.84
PrimateAI
Benign
0.44
T
PROVEAN
Benign
-0.48
N
REVEL
Benign
0.080
Sift
Benign
0.74
T
Sift4G
Benign
0.88
T
Polyphen
0.93
P
Vest4
0.38
MVP
0.12
MPC
0.0049
ClinPred
0.013
T
GERP RS
0.99
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.031
gMVP
0.26
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs143216051; hg19: chr2-127447840; COSMIC: COSV52146114; API